Deltec Asset Management’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

Deltec Asset Management’s Portfolio LABP Stock Details LABP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$1.07M	–	176
2024 Q1	$1.07M	Buy	+50,000	New	+$332K	0.21%	82

Deltec Asset Management's LABP Position: Q2 2024 in Review

Deltec Asset Management sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q2 2024, closing a stake of 50,000 shares — an estimated $1.07M sold.

Deltec Asset Management first reported a position in LABP in Q1 2024 and held it in 1 quarter. The position peaked at $1.07M in Q1 2024. 0 funds tracked by Wall St. Rank hold LABP as of Q2 2024.

Deltec Asset Management reported no remaining Landos Biopharma, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Deltec Asset Management sold 50,000 Landos Biopharma, Inc. Common Stock shares in Q2 2024, an estimated $1.07M.
Deltec Asset Management first reported a position in Landos Biopharma, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Deltec Asset Management's Landos Biopharma, Inc. Common Stock position peaked at $1.07M in Q1 2024.
0 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q2 2024.

Based on Deltec Asset Management's 13F filing for Q2 2024, filed 16 Jul 2024.